Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83,148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP).
Ji L, Song W, Fang H, Li W, Geng J, Wang Y, Guo L, Cai H, Yang T, Li H, Yang G, Li Q, Liu K, Li S, Liu Y, Shi F, Li X, Gao X, Tian H, Ji Q, Su Q, Zhou Z, Wang W, Zhou Z, Li X, Xu Y, Ning Z, Cao H, Pan D, Yao H, Lu X, Jia W. Ji L, et al. Among authors: wang w, wang y. Sci Bull (Beijing). 2021 Aug 15;66(15):1571-1580. doi: 10.1016/j.scib.2021.03.019. Epub 2021 Mar 23. Sci Bull (Beijing). 2021. PMID: 36654286 Free article. Clinical Trial.
Covalent immobilization of chitosan and heparin on PLGA surface.
Wang XH, Li DP, Wang WJ, Feng QL, Cui FZ, Xu YX, Song XH. Wang XH, et al. Among authors: wang wj. Int J Biol Macromol. 2003 Nov;33(1-3):95-100. doi: 10.1016/s0141-8130(03)00072-2. Int J Biol Macromol. 2003. PMID: 14599590
Crosslinked collagen/chitosan matrix for artificial livers.
Wang XH, Li DP, Wang WJ, Feng QL, Cui FZ, Xu YX, Song XH, van der Werf M. Wang XH, et al. Among authors: wang wj. Biomaterials. 2003 Aug;24(19):3213-20. doi: 10.1016/s0142-9612(03)00170-4. Biomaterials. 2003. PMID: 12763448
[Analysis of two phosgene poisoning accidents].
Shi QH, Zhu RK, Huang L, Rong KP, Xu YP, Wang W. Shi QH, et al. Among authors: wang w. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2019 Feb 20;37(2):147-149. doi: 10.3760/cma.j.issn.1001-9391.2019.02.015. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2019. PMID: 30929360 Chinese. No abstract available.
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
Kawazoe A, Xu RH, García-Alfonso P, Passhak M, Teng HW, Shergill A, Gumus M, Qvortrup C, Stintzing S, Towns K, Kim TW, Shiu KK, Cundom J, Ananda S, Lebedinets A, Fu R, Jain R, Adelberg D, Heinemann V, Yoshino T, Elez E; LEAP-017 Investigators. Kawazoe A, et al. J Clin Oncol. 2024 Jun 4:JCO2302736. doi: 10.1200/JCO.23.02736. Online ahead of print. J Clin Oncol. 2024. PMID: 38833658
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.
Shen M, Chen S, Han X, Hao Y, Wang J, Li L, Chen T, Wang B, Zou L, Zhang T, Zhang W, Han X, Wang W, Yu H, Li K, Liu S, Jin A. Shen M, et al. Among authors: wang w. Cancer Immunol Immunother. 2024 Jun 4;73(8):150. doi: 10.1007/s00262-024-03729-y. Cancer Immunol Immunother. 2024. PMID: 38832948
83,148 results
You have reached the last available page of results. Please see the User Guide for more information.